Biologic

Biologic company information, Employees & Contact Information

Explore related pages

Related company profiles:

>> Measurement Solutions for Science & Industry >> Good measurements lead to good decisions. Trusted by over 900 academic and industrial organizations worldwide, BioLogic measurement instruments, including potentiostats, battery cyclers, impedance analyzers, and scanning probe workstations play a decisive role in the design, optimization, and manufacture of the products of tomorrow. Our ultra-precise and ultra-accurate measurement instruments, powered by our advanced, user-friendly software help scientists and industrial experts in such fields as battery testing and cycling, material testing and general electrochemistry and spectroscopy.

Company Details

Employees
212
Founded
-
Address
4, Rue Vaucanson, Seyssinet-Pariset,auvergne-Rhone-Alpes 38170,france
Industry
Computers And Electronics Manufacturing
NAICS
Computer and Electronic Product Manufacturing
Bare Printed Circuit Board Manufacturing
Semiconductor and Related Device Manufacturing
Capacitor, Resistor, Coil, Transformer, and Other Inductor Manufacturing
Electronic Connector Manufacturing
Printed Circuit Assembly (Electronic Assembly) Manufacturing
Other Electronic Component Manufacturing
HQ
Seyssinet-Pariset, Auvergne-Rhone-Alpes
Looking for a particular Biologic employee's phone or email?

Biologic Questions

News

Melbourne start-up launches 'biological computer' made of human brain cells - Australian Broadcasting Corporation

Melbourne start-up launches 'biological computer' made of human brain cells Australian Broadcasting Corporation

Response to Biologics and Clinical Remission in the Adult German Asthma Net Severe Asthma Registry Cohort - ScienceDirect.com

Response to Biologics and Clinical Remission in the Adult German Asthma Net Severe Asthma Registry Cohort ScienceDirect.com

The Underlying Economics of Unbranded Biologics - Center for Biosimilars

The Underlying Economics of Unbranded Biologics Center for Biosimilars

Top nine biological drugs by sales in 2023 - Generics and Biosimilars Initiative

Top nine biological drugs by sales in 2023 Generics and Biosimilars Initiative

Project to explore speed up of mRNA vaccine production deployable for local outbreaks - CEPI

Project to explore speed up of mRNA vaccine production deployable for local outbreaks CEPI

The Stelara Biosimilar Price War: How PBM-Affiliated Private Labels Are Reshaping the Market - Drug Channels

The Stelara Biosimilar Price War: How PBM-Affiliated Private Labels Are Reshaping the Market Drug Channels

Understanding immune drift in biologic therapy for inflammatory skin diseases - News-Medical

Understanding immune drift in biologic therapy for inflammatory skin diseases News-Medical

Turns Out That Biosimilars Do Impact Biologic Drug Costs - MedPage Today

Turns Out That Biosimilars Do Impact Biologic Drug Costs MedPage Today

uptake of the coastal ocean is dominated by biological carbon fixation - Nature

uptake of the coastal ocean is dominated by biological carbon fixation Nature

Biosimilars Expand Access to Essential Biological Therapies - HIT Consultant

Biosimilars Expand Access to Essential Biological Therapies HIT Consultant

‘Similar biologics’ approved and marketed in India - Generics and Biosimilars Initiative

‘Similar biologics’ approved and marketed in India Generics and Biosimilars Initiative

Humira Biosimilar Price War Update: Should We Be Glad that CVS Health and Express Scripts Are Using Private Label Products to Pop the Gross-to-Net Bubble? - Drug Channels

Humira Biosimilar Price War Update: Should We Be Glad that CVS Health and Express Scripts Are Using Private Label Products to Pop the Gross-to-Net Bubble? Drug Channels

Inflammatory cells may persist despite biologic therapy in severe asthma - News-Medical

Inflammatory cells may persist despite biologic therapy in severe asthma News-Medical

Rituximab ‘similar biologic’ shows equivalent efficacy and safety - Generics and Biosimilars Initiative

Rituximab ‘similar biologic’ shows equivalent efficacy and safety Generics and Biosimilars Initiative

Labman leads international project to develop AI-powered bioreactor platform for next-generation biologics - News-Medical

Labman leads international project to develop AI-powered bioreactor platform for next-generation biologics News-Medical

Biosimilars of epoetin alfa - Generics and Biosimilars Initiative

Biosimilars of epoetin alfa Generics and Biosimilars Initiative

Small molecule versus biological drugs - Generics and Biosimilars Initiative

Small molecule versus biological drugs Generics and Biosimilars Initiative

Biosimilars of bevacizumab - Generics and Biosimilars Initiative

Biosimilars of bevacizumab Generics and Biosimilars Initiative

Infliximab ‘similar biologic’ receives Indian approval - Generics and Biosimilars Initiative

Infliximab ‘similar biologic’ receives Indian approval Generics and Biosimilars Initiative

Alkem launches first cetuximab similar biologic in India - Generics and Biosimilars Initiative

Alkem launches first cetuximab similar biologic in India Generics and Biosimilars Initiative

Biosimilars approved in the US - Generics and Biosimilars Initiative

Biosimilars approved in the US Generics and Biosimilars Initiative

First infliximab ‘similar biologic’ launched in India - Generics and Biosimilars Initiative

First infliximab ‘similar biologic’ launched in India Generics and Biosimilars Initiative

Darbepoetin alfa ‘similar biologic’ launched in India - Generics and Biosimilars Initiative

Darbepoetin alfa ‘similar biologic’ launched in India Generics and Biosimilars Initiative

The Biological Productivity of the Ocean | Learn Science at Scitable - Nature

The Biological Productivity of the Ocean | Learn Science at Scitable Nature

Adalimumab similar biologic launched in India - Generics and Biosimilars Initiative

Adalimumab similar biologic launched in India Generics and Biosimilars Initiative

Inside McKesson’s Acquisition of Biologics Specialty Pharmacy - Drug Channels

Inside McKesson’s Acquisition of Biologics Specialty Pharmacy Drug Channels

Bevacizumab ‘similar biologic’ Versavo launched in India - Generics and Biosimilars Initiative

Bevacizumab ‘similar biologic’ Versavo launched in India Generics and Biosimilars Initiative

Intas launches rituximab ‘similar biologic’ in India - Generics and Biosimilars Initiative

Intas launches rituximab ‘similar biologic’ in India Generics and Biosimilars Initiative

Biosimilars of rituximab - Generics and Biosimilars Initiative

Biosimilars of rituximab Generics and Biosimilars Initiative

Filgrastim follow-on biological approved in Brazil - Generics and Biosimilars Initiative

Filgrastim follow-on biological approved in Brazil Generics and Biosimilars Initiative

$19.5B Market Opportunity: AI Drug Discovery Pioneer Nanyang Biologics Goes Public in $1.5B SPAC Deal - Stock Titan

$19.5B Market Opportunity: AI Drug Discovery Pioneer Nanyang Biologics Goes Public in $1.5B SPAC Deal Stock Titan

Comparison of the cost of development of biologicals and biosimilars - Generics and Biosimilars Initiative

Comparison of the cost of development of biologicals and biosimilars Generics and Biosimilars Initiative

Hetero launches adalimumab similar biologic in India - Generics and Biosimilars Initiative

Hetero launches adalimumab similar biologic in India Generics and Biosimilars Initiative

Biosimilars of infliximab - Generics and Biosimilars Initiative

Biosimilars of infliximab Generics and Biosimilars Initiative

(PDF) Biologics versus small molecules: Drug costs and patient access - researchgate.net

(PDF) Biologics versus small molecules: Drug costs and patient access researchgate.net

Human insulin ‘similar biologic’ InsuTrend launched in India - Generics and Biosimilars Initiative

Human insulin ‘similar biologic’ InsuTrend launched in India Generics and Biosimilars Initiative

Biosimilars of teriparatide - Generics and Biosimilars Initiative

Biosimilars of teriparatide Generics and Biosimilars Initiative

Biosimilars of filgrastim - Generics and Biosimilars Initiative

Biosimilars of filgrastim Generics and Biosimilars Initiative

Regulatory pathways for approval of biological products in Brazil - Generics and Biosimilars Initiative

Regulatory pathways for approval of biological products in Brazil Generics and Biosimilars Initiative

WuXi Biologics Revenue Jumps 10%, Non-COVID Business Surges 13% With Massive $18.5B Backlog - Stock Titan

WuXi Biologics Revenue Jumps 10%, Non-COVID Business Surges 13% With Massive $18.5B Backlog Stock Titan

Biosimilars of darbepoetin alfa - Generics and Biosimilars Initiative

Biosimilars of darbepoetin alfa Generics and Biosimilars Initiative

Safety concerns limit similar biologics uptake in India - Generics and Biosimilars Initiative

Safety concerns limit similar biologics uptake in India Generics and Biosimilars Initiative

Sandoz makes biological deal in China - Generics and Biosimilars Initiative

Sandoz makes biological deal in China Generics and Biosimilars Initiative

Samsung Biologics posts record 2024 sales, operating profit as it goes global - The Korea Economic Daily Global Edition

Samsung Biologics posts record 2024 sales, operating profit as it goes global The Korea Economic Daily Global Edition

(PDF) Which Is the Best Biologic for Nasal Polyps: Dupilumab, Omalizumab, or Mepolizumab? A Network Meta-Analysis - researchgate.net

(PDF) Which Is the Best Biologic for Nasal Polyps: Dupilumab, Omalizumab, or Mepolizumab? A Network Meta-Analysis researchgate.net

Cadila launches two new similar biologics in India - Generics and Biosimilars Initiative

Cadila launches two new similar biologics in India Generics and Biosimilars Initiative

Cipla launches first etanercept ‘similar biologic’ in India - Generics and Biosimilars Initiative

Cipla launches first etanercept ‘similar biologic’ in India Generics and Biosimilars Initiative

45 US states have passed biosimilar substitution laws - Generics and Biosimilars Initiative

45 US states have passed biosimilar substitution laws Generics and Biosimilars Initiative

Indian regulator approves first trastuzumab ‘similar biologic’ - Generics and Biosimilars Initiative

Indian regulator approves first trastuzumab ‘similar biologic’ Generics and Biosimilars Initiative

Analysis of biological sales for OECD countries - Generics and Biosimilars Initiative

Analysis of biological sales for OECD countries Generics and Biosimilars Initiative

Asia Pacific countries: future demand for biosimilars - Generics and Biosimilars Initiative

Asia Pacific countries: future demand for biosimilars Generics and Biosimilars Initiative

Enoxaparin biosimilar or not - Generics and Biosimilars Initiative

Enoxaparin biosimilar or not Generics and Biosimilars Initiative

(PDF) Deep Sea Minerals: Manganese Nodules, a physical, biological, environmental and technical review. - researchgate.net

(PDF) Deep Sea Minerals: Manganese Nodules, a physical, biological, environmental and technical review. researchgate.net

(PDF) Chemical and biological aspects of Amaryllidaceae alkaloids - researchgate.net

(PDF) Chemical and biological aspects of Amaryllidaceae alkaloids researchgate.net

Developing our own biologic drugs - The Daily Star

Developing our own biologic drugs The Daily Star

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant